Scientific Advisory Board

Our Scientific Advisory Board is composed by specialist in senescence field and clinicians recognized in the development of innovative therapies. They provide essential advices for the scientific strategy of the company.

Scientific Advisory Board

Pr. Michail Ignatiadis MD, PhD

SAB member

Oncologist at Jules Bordet Institute and director of oncology clinic

Dr. Fabrizio d’Adda di Fagagna, PhD

SAB member

Specialist of senescence induced by DNA damages

Dr. Florence Lhospice, PhD

SAB member

Expert in preclinical and CMC development for Antibody-Drug Conjugated

Pr. Cleo Bishop, PhD

SAB Member

Specialist of senescence and discovery of new senolytic compounds